Please assess the completion status of the following clinical trial:

Trial Title: PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Subjects are eligible for inclusion if they meet the following inclusion criteria:~* Men and women \> 18 years of age~* Written informed consent from the subject~* Stable CAD~* Stable medical condition, will be compliant and able to comply with the requirements of the protocol~Exclusion Criteria:~* Subjects must NOT meet any of the following exclusion criteria:~* Planned CABG~* Hospitalization for acute coronary syndrome if troponin level is \>0.1 ng/mL in the preceding 6 weeks~* Hospitalization for ST-segment acute myocardial infarction (STEMI) in the preceding 12 weeks~* Subjects with chronic inflammatory disease (e.g., RA), inflammatory bowel disease, recent (12 weeks) systemic or localized infection (the latter requiring clinical intervention), or major surgery~* hs-CRP \>15 mg/L repeated on at least 2 occasions \>24 hours apart due to non-cardiovascular systemic inflammatory conditions (e.g., rheumatoid disease)~* Acute or chronic heart failure as defined by the NYHA classification as functional Class III or Class IV

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).